2008
DOI: 10.1002/ajmg.c.30188
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenic significance of deletions distal to the currently described Wolf–Hirschhorn syndrome critical regions on 4p16.3

Abstract: Within recent years, numerous individuals have been identified with terminal 4p microdeletions distal to the currently described critical regions for the Wolf-Hirschhorn syndrome (WHS). Some of these individuals do not display features consistent with WHS whereas others have a clinical phenotype with some overlap to the WHS phenotype. In this review we discuss the genetic and clinical presentation of these cases in an attempt to understand the consequence of monosomy of the genes distal to the proposed critica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
42
1
1

Year Published

2009
2009
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(46 citation statements)
references
References 19 publications
2
42
1
1
Order By: Relevance
“…The separation of rodent Fgfrl1 from the WHSCRs may, therefore, be the result of a more recent event, perhaps involving an inversion. This complicates the interpretation of the large-scale mouse deletions, as described by Näf et al (Näf et al, 2001), since the emerging model of human WHS predicts that many mutations in this region are implicated in the syndrome: deletion of any of at least three non-overlapping regions in 4p16.3 can be pathogenic for the craniofacial features of WHS (South et al, 2008). Thus, it is likely that in humans, heterozygous mutations in both FGFRL1 and a homologue of an undefined gene that is eliminated in WHS mouse models with large-scale deletions that do not target Fgfrl1 (Näf et al, 2001), collectively contribute to the craniofacial features of WHS.…”
Section: Dmmbiologistsorg 288mentioning
confidence: 99%
“…The separation of rodent Fgfrl1 from the WHSCRs may, therefore, be the result of a more recent event, perhaps involving an inversion. This complicates the interpretation of the large-scale mouse deletions, as described by Näf et al (Näf et al, 2001), since the emerging model of human WHS predicts that many mutations in this region are implicated in the syndrome: deletion of any of at least three non-overlapping regions in 4p16.3 can be pathogenic for the craniofacial features of WHS (South et al, 2008). Thus, it is likely that in humans, heterozygous mutations in both FGFRL1 and a homologue of an undefined gene that is eliminated in WHS mouse models with large-scale deletions that do not target Fgfrl1 (Näf et al, 2001), collectively contribute to the craniofacial features of WHS.…”
Section: Dmmbiologistsorg 288mentioning
confidence: 99%
“…[6][7][8] Of patients meeting the minimal diagnostic criteria, 9 the smallest terminal deletion identified was B1.9 Mb, 1, 9,10 suggesting that genes within this interval of 4p16.3 are responsible for the core features of WHS. 8,11 Beyond this region, the loss of additional critical genes appears to be responsible for variably present features, such as congenital malformations or hearing loss. 1,5,8 The identification of patients with atypical 4p deletions has provided key insight into which regions of 4p16.3 may (or may not) contribute to the pathogenesis of WHS.…”
Section: Introductionmentioning
confidence: 99%
“…For example, small terminal deletions (up to 400 kb) have been inherited from phenotypically normal individuals; [12][13][14] indicating that monosomy of this region is likely benign. 11 Between B1.8 and 2.0 Mb from the 4p terminus, two adjacent critical regions were proposed based on the smallest region of overlap (SRO) among the deletions of individuals with or without the core features of WHS. The more proximal critical region (WHSCR) was delineated first 15 and mapping within this 165-kb interval identified two genes, WHSC1 and WHSC2.…”
Section: Introductionmentioning
confidence: 99%
“…Patients with small terminal deletions, that do not span the LETM1 gene, have been reported to experience seizures. 4,5 The current report in DMCN establishes a critical platform for the assessment of future cohorts of patients with microdeletions.…”
mentioning
confidence: 99%
“…Deterioration was significantly associated with older age, delayed walking debut, and severe neurological impairment. 4 Self-reported causes…”
mentioning
confidence: 99%